Pediatrics and CMT

CMT, it starts in infancy…


…and lays dormant in the body until one day… the symptoms start to appear.

View Infographic

HNF acknowledges that CMT is a childhood disease and advocates for early intervention to limit the progression of the disease. We need to prepare for pediatric clinical trials!

It’s important to document the impact of CMT on the quality of life in childhood. 

Participate by confidentially sharing your child’s health data. Join HNF’s Global Registry for Inherited Neuropathies (GRIN) & complete the Natural History study, followed by the Pediatric Quality of Life survey.

Note: For your child to participate in this study, please complete the natural history study and health and development survey. Once those two studies are completed, you can bypass the other listed studies and select pCMT QoL.


Did you Know?



Of CMT Patients Reported the Absence of Reflexes

As a pediatric neuromuscular specialist, I understand how critical it is to collect information from parents and caregivers on the challenges and delays they face to get their child diagnosed with CMT, presenting symptoms, similar health problems in the family and their interest in participating in clinical trials. GRIN patient registry collects such critical information needed to pivot the care provided for children with CMT to the next level.

Dr. Veerapandiyan

Pediatric Neurologist, University of Arkansas

CME Education for Credits

View The AANEM Charcot-Marie-Tooth Continuing Education Course for a detailed look at this CMT continuing education course.

Participants will acquire skills to:

(1) Diagnose CMT based on common symptomology;

(2) Discuss work-up and surgical treatment options for the very young to adults;

(3) Identify potential therapies and bracing that may improve quality of life for those diagnosed and their care-givers.

Data from GRIN shows pediatric patients ages 0-17 diagnosed with CMT are broadly affected with a wide spectrum of symptoms. CMT impacts quality of life starting in childhood. 22.3% of CMT patients experienced initial symptoms during early childhood, between ages 0 and 5 years. About half (50.5%) of CMT patients had symptoms onset before the age of 16 years. 55% of symptoms were noticed by family members before official diagnosis. See chart below.

Peds stat GRIN

Kids Resources & Initiatives

Team CMT Kids

James And Lindsey Team CMT KidsFounded 2013 encouraging kids to stay active, proudly wear their Team CMTkids shirt to raise awareness and funds for CMT research.

Amazon Wish List

HNF’s focus is to support people living with CMT and their families with critical information to improve their quality of life, and we are dedicated to finding treatments for CMT. We provide a strong organizational voice to those living with CMT worldwide.

The HNF team and supporters have curated an ULTIMATE wishlist of CMT-friendly products on Amazon to make life with CMT easier!

We hope you find this list helpful and choose HNF as your AmazonSmile Charity before you shop!

School Outreach Program

Launching discussions about CMT and disabilities in schools.

HNF believes that it is important for educators and other school professionals to know about CMT, given the importance of physical activity and services such as occupational therapy for kids growing up with the disease.

No Child Left Behind (NCLB)

NCLB seeks to ensure that all children have a “fair, equal and significant opportunity to receive a high quality education.” It requires that all groups of children make adequate yearly progress, including children with disabilities, and requires that teachers are highly qualified. Children taking standardized tests required by NCLB are entitled to the accommodations that are set forth in their 504 Plan or IEP. For kids with CMT, this might mean extra time on standardized tests or assistive technology.

Patient Focused Drug Development (PFDD) with FDA Kids panel hosted by HNF

On Friday, September 28, 2018 HNF hosted an Externally-led Patient Focused Drug Development (PFDD) Meeting.

In attendance were patients, caregivers, Government Officials, Healthcare Providers, Industry Representatives, and Payors.

The PFDD meeting was an opportunity for patients and families to inform the FDA, drug developers and other key stakeholders, on the true burdens of living with CMT and how patients view the benefits and risks of treatments for CMT. Included was a kids panel which amplified the voices of young patient’s.

Care Guidelines

Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease

Other Resources

Please visit our Patient Resources, School & College segment for more resources including Webinars.

Learn more on this topic

Latest News and Related Blog Posts

Hypotonia & CMT

Hypotonia & CMT

Hypotonia, or low muscle tone, can be caused by a variety of factors, including genetic conditions like Charcot-Marie-Tooth (CMT) disease